QQ客服 官方微博 反馈留言

	Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia)
	Pan, Chang Yu*; Han, Ping; Liu, Xiaoming; Yan, Shengli; Feng, Ping; Zhou, Zhiguang; Lv, Xiaofeng; Tian, Hui; Kui, Yang Jin; Su, Benli
刊名	Diabetes/Metabolism Research and Reviews
	2014
卷号	30期号:8页码:726-735
关键词	lixisenatide type 2 diabetes mellitus (T2DM) glucagon‐like peptide‐1 (GLP‐1) receptor agonists Asia
ISSN号	1520-7560
DOI	10.1002/dmrr.2541
URL标识	查看原文
WOS记录号	WOS:000345291300013
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3317395
专题	中南大学
作者单位	1.[Pan, Chang Yu 2.Tian, Hui] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China.
推荐引用方式 GB/T 7714	Pan, Chang Yu*,Han, Ping,Liu, Xiaoming,et al. Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia)[J]. Diabetes/Metabolism Research and Reviews,2014,30(8):726-735.
APA	Pan, Chang Yu*.,Han, Ping.,Liu, Xiaoming.,Yan, Shengli.,Feng, Ping.,...&Niemoeller, Elisabeth.(2014).Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia).Diabetes/Metabolism Research and Reviews,30(8),726-735.
MLA	Pan, Chang Yu*,et al."Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia)".Diabetes/Metabolism Research and Reviews 30.8(2014):726-735.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。